A portable graphical link to your paper (QR code) is provided below. If the code is placed, for example, on a poster, your paper can be accessed through a mobile device's QR code reader.

Right click on the image below to save it to your device.

QR Code for 10.1101/2022.06.30.22277092

A signal-seeking Phase II trial of Durvalumab and Tremelimumab Focused on Advanced, Rare and Less Common Cancers